Today: 8 June 2026
ABAT Shares Jump on DOE’s $115M Lithium Grant Return
8 June 2026
2 mins read

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

NEW YORK, June 8, 2026, 08:03 EDT

American Battery Technology Co (ABAT) rallied in premarket trading Monday, climbing 29.58% to $4.03 on Google Finance after news that the U.S. Department of Energy brought back support for the company’s planned $115 million lithium refinery in Nevada. Shares ended Friday at $3.11.

The regular Nasdaq market wasn’t open yet in New York. Nasdaq’s premarket window is 4:00 a.m. to 9:30 a.m. ET, and the regular session starts at 9:30 a.m. and closes at 4:00 p.m. ET. So the early move came in the lighter volume of the premarket, before the main open set the across-the-board price.

The decision puts federal funding back in play for American Battery’s Tonopah Flats Lithium Project, the company’s planned lithium hydroxide plant. This material goes into some EV and storage cathodes. American Battery said the grant is fully restored, with no changes to the amount, technical targets, or commercial goals. The project timeline was adjusted for the review period.

Chief Executive Ryan Melsert said the DOE decided that “continued federal support of this project is warranted.” He also said not many grants that were cut last fall ended up winning their appeals. The company said the project’s first phase aims for output of 5,000 tonnes a year of battery-grade lithium hydroxide. American Battery Technology Company

The move is a major change from October, when Reuters said the Energy Department ended a $57.7 million grant tied to American Battery’s lithium hydroxide project. The company had to match the grant. At that time, about $52 million in DOE funds were left for reimbursement. American Battery said it would appeal and seek dispute resolution.

ABAT shares remain volatile. The 52-week range is $1.20 to $11.49, according to Google Finance. Volume hit 20.65 million shares on Friday, topping the average of 5.71 million.

American Battery came into the week with a stronger operating picture than last year, but the business is still small. On May 11, the company posted fiscal third-quarter revenue of $7.8 million, a 64% jump from the previous quarter. It also reported its first positive gross margin of $0.7 million—sales after production costs. CEO Melsert called the gross margin “a major milestone.” GlobeNewswire

The move followed a tough final regular session for U.S. stocks. According to Reuters, the Nasdaq Composite dropped 4.18% on Friday, marking its steepest one-day percentage slide since April 2025. The S&P 500 ended down 2.64%, and the Dow shed 1.35% after strong jobs numbers raised new rate-hike fears.

American Battery is chasing funding in a packed U.S. critical-minerals sector. DOE documents show the federal government has already backed bigger projects, such as a $2.26 billion loan for Lithium Americas’ Thacker Pass and a $2 billion conditional commitment to Redwood Materials’ Nevada battery campus this week. That new money isn’t final yet.

Lithium sentiment has improved from earlier in 2024 and 2025. Last month Reuters said Albemarle, the biggest lithium producer, posted profit well ahead of what Wall Street was looking for as lithium prices came back. Sales for its lithium unit climbed 70%.

Lithium’s rally isn’t free of risk. Reuters columnist Andy Home wrote June 5 that CME lithium hydroxide contracts are up 86% this year, back over $20,000 a metric ton. Benchmark Mineral Intelligence, BNP Paribas and Citi say prices could slide again if sidelined supply comes back.

That’s still the main bearish case for ABAT. Even with the grant back in place, the project faces risk from permits, funding, building, and swings in mineral prices. American Battery flagged those uncertainties itself, citing needed regulatory signoffs, investment approval, open financing, and price volatility as factors that could change its plans.

For Monday, traders are watching if the premarket buying sticks after the bell. Next up, the Street wants to see proof the restored grant actually moves construction ahead, delivers customer deals and boosts cash flow—share price isn’t enough.

Stock Market Today

  • Dow Jones, Nasdaq, S&P 500 Weekly Preview: Anticipating SpaceX's Record IPO
    June 8, 2026, 9:16 AM EDT. This week, major U.S. stock indexes-the Dow Jones, Nasdaq, and S&P 500-are positioned for heightened activity as investors prepare for SpaceX's landmark initial public offering (IPO). The IPO is expected to be the largest in history, potentially influencing market sentiment and trading volumes. Market participants are monitoring this event closely, assessing its impact on tech and aerospace sectors, which could drive volatility across equities. The SpaceX listing represents a significant test for investor appetite amid a complex economic backdrop, combining innovation-driven optimism with broader market uncertainty.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
NANO Nuclear Stock Bounces, Investors Eye What’s Next
Previous Story

NANO Nuclear Stock Bounces, Investors Eye What’s Next

SUNation Surges Premarket After Announcing Suniva Merger, Pushing Solar Startup Toward Nasdaq Manufacturing
Next Story

SUNation Surges Premarket After Announcing Suniva Merger, Pushing Solar Startup Toward Nasdaq Manufacturing

Go toTop